Authors:
Kalinina, T
Riu, A
Fischer, L
Will, H
Sterneck, M
Citation: T. Kalinina et al., A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis, HEPATOLOGY, 34(2), 2001, pp. 385-394
Authors:
Leifeld, L
Ramakers, J
Schneiders, AM
Dumoulin, FL
Sterneck, M
Muller, A
Sauerbruch, T
Spengler, U
Citation: L. Leifeld et al., Intrahepatic MxA expression is correlated with interferon-alpha expressionin chronic and fulminant hepatitis, J PATHOLOGY, 194(4), 2001, pp. 478-483
Authors:
Broering, DC
Mueller, L
Ganschow, R
Kim, JS
Achilles, EG
Schafer, H
Gundlach, M
Fischer, L
Sterneck, M
Hillert, C
Helmke, K
Izbicki, JR
Burdelski, M
Rogiers, X
Citation: Dc. Broering et al., Is there still a need for living-related liver transplantation in children?, ANN SURG, 234(6), 2001, pp. 713-721
Authors:
Fischer, L
Sterneck, M
Gahlemann, CG
Malago, M
Rogiers, X
Broelsch, CE
Citation: L. Fischer et al., A prospective study comparing safety and efficacy of mycophenolate mofetilversus azathioprine in primary liver transplant recipients, TRANSPLAN P, 32(7), 2000, pp. 2125-2127
Authors:
Fischer, L
Sterneck, M
Zollner, B
Rogiers, X
Citation: L. Fischer et al., Lamivudine improves the prognosis of patients with hepatitis B after livertransplantation, TRANSPLAN P, 32(7), 2000, pp. 2128-2130
Authors:
Santantonio, T
Gunther, S
Sterneck, M
Rendina, M
Messner, M
Launois, B
Francavilla, A
Pastore, G
Will, H
Citation: T. Santantonio et al., Liver graft infection by HBVS-gene mutants in transplant patients receiving long-term HBlg prophylaxis, HEP-GASTRO, 46(27), 1999, pp. 1848-1854
Authors:
Gunther, S
von Breunig, F
Santantonio, T
Jung, MC
Gaeta, GB
Fischer, L
Sterneck, M
Will, H
Citation: S. Gunther et al., Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure, J HEPATOL, 30(5), 1999, pp. 749-754
Authors:
Fischer, L
Sterneck, M
Muller-Ruchholtz, C
Gish, R
Will, H
Citation: L. Fischer et al., Hepatitis B virus variants associated with clinically severe recurrence after liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 492-493
Authors:
Fischer, L
Sterneck, M
Valentin-Gamazo, C
Feucht, HH
Malago, M
Broelsch, CE
Citation: L. Fischer et al., Treatment of severe recurrent hepatitis C after liver transplantation withribavirin plus interferon alpha, TRANSPLAN P, 31(1-2), 1999, pp. 494-495